118 related articles for article (PubMed ID: 9622302)
1. Appearance of TSH receptor antibody and hyperthyroidism associated with metastatic thyroid cancer after total thyroidectomy.
Yoshimura Noh J; Mimura T; Kawano M; Hamada N; Ito K
Endocr J; 1997 Dec; 44(6):855-9. PubMed ID: 9622302
[TBL] [Abstract][Full Text] [Related]
2. A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma.
Ishihara T; Ikekubo K; Shimodahira M; Iwakura T; Kobayashi M; Hino M; Oobayashi M; Kohno K; Kimura K; Kawamura S; Kurahachi H
Endocr J; 2002 Apr; 49(2):241-5. PubMed ID: 12081245
[TBL] [Abstract][Full Text] [Related]
3. A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.
Aoyama M; Takizawa H; Tsuboi M; Nakagawa Y; Tangoku A
Endocr J; 2017 Dec; 64(12):1143-1147. PubMed ID: 28883260
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism with potent thyroid-stimulation-blocking antibodies and negative thyroid-stimulating antibodies after subtotal thyroidectomy for Graves' disease with follicular thyroid carcinoma.
Sugimoto M; Nakamura S; Hattori J; Yamada T; Horiya Y; Hara S; Shima H
Intern Med; 1993 Mar; 32(3):266-8. PubMed ID: 8101110
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
7. Metastatic thyroid cancer with hyperthyroidism.
Kobayashi T; Asakawa H; Tamaki Y; Nagata I; Monden M
Eur J Surg; 1997 Jan; 163(1):67-8. PubMed ID: 9116114
[No Abstract] [Full Text] [Related]
8. Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism.
Yunta PJ; Ponce JL; Prieto M; López-Aznar D; Sancho-Fornos S
Ann Endocrinol (Paris); 2001 Jun; 62(3):226-9. PubMed ID: 11458174
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism associated with metastatic thyroid carcinoma.
Steffensen FH; Aunsholt NA
Clin Endocrinol (Oxf); 1994 Nov; 41(5):685-7. PubMed ID: 7828360
[TBL] [Abstract][Full Text] [Related]
12. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases.
Kasagi K; Takeuchi R; Miyamoto S; Misaki T; Inoue D; Shimazu A; Mori T; Konishi J
Clin Endocrinol (Oxf); 1994 Mar; 40(3):429-34. PubMed ID: 8187309
[TBL] [Abstract][Full Text] [Related]
13. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
16. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.
Shong YK; Cho BY; Hong SK; Lee HK; Koh CS; Min HK
Korean J Intern Med; 1989 Jul; 4(2):118-24. PubMed ID: 2577256
[TBL] [Abstract][Full Text] [Related]
18. The beginnings of radioiodine therapy of metastatic thyroid carcinoma: a memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient.
Siegel E
Cancer Biother Radiopharm; 1999 Apr; 14(2):71-9. PubMed ID: 10850290
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
20. [Metastasis of differentiated follicular thyroid carcinoma to the ciliary body].
Lommatzsch PK
Klin Monbl Augenheilkd; 1994 Nov; 205(5):309-13. PubMed ID: 7844948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
